Get the latest Science News and Discoveries
Phase I study for human monoclonal antibody for Lyme disease demonstrates safety, tolerability, pharmacokinetics - EurekAlert!
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
None
Or read this on Eureka Alert